Evidence map›Paper›PMID 25100952›Full record

ArticleFrontiers in systems neuroscience2014

How cognitive enhancement can change our duties.

Filippo Santoni de Sio, Nadira Faulmüller, Nicole A Vincent

Abstract read
In one paragraph

Article in Frontiers in systems neuroscience, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Cognitive Enhancement, Hyperagency, and Responsibility Explosion.The Journal of medicine and philosophy · 2024
    Article
  2. Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  3. Motives and Side-Effects of Microdosing With Psychedelics Among Users.The international journal of neuropsychopharmacology · 2019
    Article
  4. Article
  5. Article
  6. Article
  7. Sleep Deprivation Impairs and Caffeine Enhances My Performance, but Not Always Our Performance.Personality and social psychology review : an official journal of the Society for Personality and Social Psychology, Inc · 2017
    Article
  8. Article
  9. Article
  10. Article
  11. The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2015
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Filippo Santoni de SioDepartment Values, Technology and Innovation, Faculty Technology, Policy and Management, Delft University of Technology Delft, Netherlands.
Nadira FaulmüllerDepartment Values, Technology and Innovation, Faculty Technology, Policy and Management, Delft University of Technology Delft, Netherlands ; Department of Experimental Psychology, University of Oxford Oxford, UK.
Nicole A VincentDepartment Values, Technology and Innovation, Faculty Technology, Policy and Management, Delft University of Technology Delft, Netherlands ; Department of Philosophy, Georgia State University Atlanta, GA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This theoretical paper draws the scientific community's attention to how pharmacological cognitive enhancement may impact on society and law. Namely, if safe, reliable, and effective techniques to enhance mental performance are eventually developed, then this may under some circumstances impose new duties onto people in high-responsibility professions-e.g., surgeons or pilots-to use such substances to minimize risks of adverse outcomes or to increase the likelihood of good outcomes. By discussing this topic, we also hope to encourage scientists to bring their expertise to bear on this current public debate.

Indexed as

cognitive enhancementethicslawmental capacitymethylphenidatemodafinilneuroenhancementprofessional duties

Identifiers

PMID25100952
PMCPMC4102166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.